» Articles » PMID: 10430654

Mouse VDAC Isoforms Expressed in Yeast: Channel Properties and Their Roles in Mitochondrial Outer Membrane Permeability

Overview
Journal J Membr Biol
Date 1999 Aug 3
PMID 10430654
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

The channel-forming protein called VDAC forms the major pathway in the mitochondrial outer membrane and controls metabolite flux across that membrane. The different VDAC isoforms of a species may play different roles in the regulation of mitochondrial functions. The mouse has three VDAC isoforms (VDAC1, VDAC2 and VDAC3). These proteins and different versions of VDAC3 were expressed in yeast cells (S. cerevisiae) missing the major yeast VDAC gene and studied using different approaches. When reconstituted into liposomes, each isoform induced a permeability in the liposomes with a similar molecular weight cutoff (between 3,400 and 6,800 daltons based on permeability to polyethylene glycol). In contrast, electrophysiological studies on purified proteins showed very different channel properties. VDAC1 is the prototypic version whose properties are highly conserved among other species. VDAC2 also has normal gating activity but may exist in 2 forms, one with a lower conductance and selectivity. VDAC3 can also form channels in planar phospholipid membranes. It does not insert readily into membranes and generally does not gate well even at high membrane potentials (up to 80 mV). Isolated mitochondria exhibit large differences in their outer membrane permeability to NADH depending on which of the mouse VDAC proteins was expressed. These differences in permeability could not simply be attributed to different amounts of each protein present in the isolated mitochondria. The roles of these different VDAC proteins are discussed.

Citing Articles

Developing a Novel and Optimized Yeast Model for Human VDAC Research.

Baranek-Grabinska M, Grabinski W, Musso D, Karachitos A, Kmita H Int J Mol Sci. 2024; 25(23).

PMID: 39684721 PMC: 11641349. DOI: 10.3390/ijms252313010.


The E3 ubiquitin ligase NEDD4-1 protects against acetaminophen-induced liver injury by targeting VDAC1 for degradation.

Zhu Y, Lei L, Wang X, Chen L, Li W, Li J Acta Pharm Sin B. 2023; 13(4):1616-1630.

PMID: 37139424 PMC: 10150139. DOI: 10.1016/j.apsb.2023.01.019.


The role of mitochondria-associated membranes mediated ROS on NLRP3 inflammasome in cardiovascular diseases.

Zhao J, Li J, Li G, Chen M Front Cardiovasc Med. 2023; 9:1059576.

PMID: 36588561 PMC: 9794868. DOI: 10.3389/fcvm.2022.1059576.


Prescription drugs and mitochondrial metabolism.

Schmidt C Biosci Rep. 2022; 42(4).

PMID: 35315490 PMC: 9016406. DOI: 10.1042/BSR20211813.


Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer.

Kobayashi Y, Takeda T, Kunitomi H, Chiwaki F, Komatsu M, Nagai S Pharmaceuticals (Basel). 2022; 15(2).

PMID: 35215239 PMC: 8880614. DOI: 10.3390/ph15020124.